{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:40:45Z","timestamp":1773412845141,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic sclerosis (SSc; scleroderma) is an autoimmune connective tissue disease that affects the skin and subcutaneous tissue, in addition to the internal organs of the whole body. Onset in childhood is uncommon; however, both patients with childhood-onset and adult-onset SSc are positive for anti-nuclear antibodies (ANAs).Detection of SSc-related anti-nuclear antibodies is often useful for predicting clinical features, disease course, and outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 5-year-old Japanese female manifested gradually progressive abnormal gait disturbance, regression of motor development, Raynaud\u2019s phenomenon, and the shiny appearance of the skin of the face and extremities at age 2. On admission, she presented a mask-like appearance, loss of wrinkles and skin folds, puffy fingers, moderate diffuse scleroderma (18\/51 of the modified Rodnan total skin thickness score), and contracture in the ankle and proximal interphalangeal joints. Grossly visible capillary hemorrhage on nail fold and severe abnormal capillaroscopy findings including bleeding, giant loop and disappearance of capillaryconsistent with the late phase in SSc. A skin biopsy showed fibrous thickening of the dermis, entrapment of an eccrine sweat glands, and thickened fiber. Chest high-resolution computed tomographic scanning demonstrated patchy areas of ill-defined air-space opacity and consolidation predominantly involving the posterior basilar aspects of the lower lobes presenting withinterstitial lung disease. Positive ANA (1:160 nucleolar and homogeneous nuclear staining by indirect fluorescent antibody technique) and double-seropositive for anti-Th\/To and anti-PM-Scl antibodies were identified. She was diagnosed with diffuse cutaneous SSc based on the Pediatric Rheumatology European Society\/American College of Rheumatology\/European League Against Rheumatism Provisional Classification Criteria for Juvenile Systemic Sclerosis and was successfully treated with immunosuppressive agents, including methylprednisolone pulses and intravenous cyclophosphamide.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We experienced the first case of juvenile SSc with anti-PM-Scl and anti-Th\/To antibodies. ILD was identified as a typical feature of patients with these autoantibodies; however, diffuse cutaneous SSc and joint contraction were uncharacteristically associated. The case showed unexpected clinical findings though the existence of SSc-related autoantibodies aids in determining possible organ involvement and to estimate the children\u2019s outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-021-00525-1","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:02:44Z","timestamp":1616245364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Joint contractures responsive to immunosuppressive therapy in a girl with childhood\u2010onset systemic sclerosis double\u2010seropositive for rare anti\u2010nucleolar autoantibodies: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-6286","authenticated-orcid":false,"given":"Riki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manao","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"525_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989\u20132003.","journal-title":"N Engl J Med"},{"key":"525_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1177\/0009922810396546","volume":"50","author":"CM Hedrich","year":"2011","unstructured":"Hedrich CM, Fiebig B, Hahn G, Suttorp M, Gahr M. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Clin Pediatr (Phila). 2011;50:604\u201314.","journal-title":"Clin Pediatr (Phila)"},{"key":"525_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MD.0b013e318189372f","volume":"87","author":"MC Arias-Nunez","year":"2008","unstructured":"Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Med (Baltim). 2008;87:272\u201380.","journal-title":"Med (Baltim)"},{"key":"525_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778\u201399.","journal-title":"Arthritis Rheum"},{"key":"525_CR5","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JVJr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246\u201355.","journal-title":"Arthritis Rheum"},{"key":"525_CR6","first-page":"1004","volume":"33","author":"K Scalapino","year":"2006","unstructured":"Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006;33:1004\u201313.","journal-title":"J Rheumatol"},{"key":"525_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4615-4857-7_6","volume":"455","author":"CM Black","year":"1999","unstructured":"Black CM. Scleroderma in children. Adv Exp Med Biol. 1999;455:35\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"525_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2397198318790494","volume":"4","author":"I Foeldvari","year":"2018","unstructured":"Foeldvari I, Klotsche J, Torok KS, Kasapcopur O, Adrovic A, Stanevicha V, et al. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroderma Relat Disord. 2018;4:49\u201361.","journal-title":"J Scleroderma Relat Disord."},{"key":"525_CR9","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1002\/art.22207","volume":"54","author":"G Martini","year":"2006","unstructured":"Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al. Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 2006;54:3971\u20138.","journal-title":"Arthritis Rheum"},{"key":"525_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/2397198318769796","volume":"4","author":"PD Sampaio-Barros","year":"2019","unstructured":"Sampaio-Barros PD, Bortoluzzo AB, Del Rio AP, Luppino-Assad AP, Andrade DC, Marques-Neto JF. Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort. J Scleroderma Rel Disord. 2019;4:43\u20138.","journal-title":"J Scleroderma Rel Disord"},{"key":"525_CR11","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20:1892\u20136.","journal-title":"J Rheumatol"},{"key":"525_CR12","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/art.1780281207","volume":"28","author":"MS Forman","year":"1985","unstructured":"Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin JA. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum. 1985;28:1356\u201361.","journal-title":"Arthritis Rheum"},{"key":"525_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3109\/14397595.2014.896494","volume":"24","author":"EH Kang","year":"2014","unstructured":"Kang EH, Kuwana M, Okazaki Y, Lee EY, Lee YJ, Lee EB, et al. Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis specific autoantibodies in dermatomyositis patients. Mod Rheumatol. 2014;24:945\u20138.","journal-title":"Mod Rheumatol"},{"key":"525_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/art.22551","volume":"57","author":"F Zulian","year":"2007","unstructured":"Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, et al. The PRES\/ACR\/EULAR provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 2007;57:203\u201312.","journal-title":"Arthritis Rheum"},{"key":"525_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117:557\u201367.","journal-title":"J Clin Invest"},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","volume":"15","author":"LI Sakkas","year":"2016","unstructured":"Sakkas LI, Bogdanos DP. Systemic sclerosis: new evidence reenforces the role of B cells. Autoimmun Rev. 2016;15:155\u201361.","journal-title":"Autoimmun Rev"},{"key":"525_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"5","author":"SID Nihtyanova","year":"2010","unstructured":"Nihtyanova SID. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol. 2010;5:112\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"525_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","volume":"50","author":"C Liaskos","year":"2017","unstructured":"Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, et al. Disease-related Autoantibody Profile in Patients With Systemic Sclerosis. Autoimmunity. 2017;50:414\u201321.","journal-title":"Autoimmunity"},{"key":"525_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/art.38994","volume":"67","author":"Y Hamaguchi","year":"2015","unstructured":"Hamaguchi Y, Kodera M, Matsushita T, Hasegawa M, Inaba Y, Usuda T, et al. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies. Arthritis Rhematol. 2015;67:1045\u201352.","journal-title":"Arthritis Rhematol"},{"key":"525_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40674-016-0050-y","volume":"2","author":"RT Domsic","year":"2016","unstructured":"Domsic RT, Medsger TA. Autoantibodies and Their Role in Scleroderma Clinical Care. Curr Treat Options in Rheum. 2016;2:239\u201351.","journal-title":"Curr Treat Options in Rheum"},{"key":"525_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/art.38428","volume":"66","author":"J D\u2019Aoust","year":"2014","unstructured":"D\u2019Aoust J, Hudson M, Tatibouet S, Wick J, Canadian Scleroderma Research Group, Mahler M, Baron M, Fritzler MJ. Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol. 2014;66:1608\u201315.","journal-title":"Arthritis Rheumatol"},{"key":"525_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/art.10760","volume":"48","author":"GM Mitri","year":"2003","unstructured":"Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th\/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 2003;48:203\u20139.","journal-title":"Arthritis Rheum"},{"key":"525_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/ard.61.9.842","volume":"61","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Kimura K, Hirakata M, Kawakame Y, Ikeada Y. Differences in autoantibody response to Th\/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis. 2002;61:842\u20136.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-021-00525-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:08:24Z","timestamp":1616245704000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00525-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00525-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Oral informed assent and written informed consent were obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Oral informed assent and written informed consent were obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analysed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}